| α-SMA | alpha-smooth muscle actin |
| ABL | abetalipoproteinemia |
| ACVR2A | Activin A Receptor Type 2A |
| ADH | Alcohol Dehydrogenase |
| AF-B1 | Aflatoxin B1 |
| AGER | advanced glycosylation end product-specific receptor |
| ALDH | Aldehyde Dehydrogenase |
| ALIOS | American Lifestyle-Induced Obesity Syndrome |
| APOB | apolipoprotein B |
| Ath+HF | atherogenic and high-fat |
| BCAA | Branched-Chain Amino Acids |
| BMI | body mass index |
| CAR | chimeric antigen receptor |
| CD-HFD | choline-deficient high-fat diet |
| CDKI1A | cyclin dependent kinase inhibitor 1A |
| c-Jun | c-Jun N-terminal kinase |
| CRISPR/Cas9 | clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9 |
| CTNNB1 | Catenin beta 1 |
| CYP2E1 | Cytochrome P450 2E1 |
| DAMPs | damage-associated molecular patterns |
| DEN | diethylnitrosamine |
| DIAMOND | diet-induced animal model of non-alcoholic fatty liver disease |
| DNMT | DNA methyltransferases |
| EPIC | European Prospective Investigation into Cancer and Nutrition |
| ER | endoplasmic reticulum |
| EZH2 | polycomb protein enhancer of zeste homolog 2 |
| FFAs | free fatty acids |
| GWAS | genome-wide association study |
| HBV | hepatitis B infection |
| HCC | hepatocellular carcinoma |
| HDAC8 | histone deacetylase 8 |
| HFD | high-fat diet |
| HFHC | high fat high cholesterol |
| Ho-FHBL | hypobetalipoproteinemia |
| HPCs | hepatic progenitor cells |
| HR | hazard ratio |
| HSCs | hepatic stellate cells |
| HSD17B13 | hydroxysteroid 17-β dehydrogenase 13 |
| ILs | interleukins |
| IgA | Immunoglobulin A |
| IR | insulin resistance |
| KO | knock-out |
| LD | lipid droplet |
| LDL | low-density lipoprotein |
| Lyso-PI | lyso-phosphatidylinositol |
| LOX-1 | lectin-like oxidized LDL receptor-1 |
| LPIAT1 | lyso-phosphatidylinositol (Lyso-PI) acyl-transferase1 |
| LPS | lipopolysaccharides |
| MAT | methionine adenosyltransferase |
| MBOAT7 | membrane bound o-acyltransferase domain-containing 7 |
| MC4R | melanocortin 4 receptor-deficient mice |
| miRNA | microRNA |
| mtDNA | mitochondrial DNA |
| MT-ND6 | mitochondrially encoded NADH dehydrogenase 6 |
| MTTP | microsomal triglyceride transfer protein large subunit gene |
| NAFLD | nonalcoholic fatty liver disease |
| NASH | nonalcoholic steatohepatitis |
| NF-κB | nuclear factor kappa-light-chain-enhancer of activated B-cells |
| NLRs | intracellular nucleotide-binding and oligomerization domain (NOD)-like receptors |
| OR | odd ratio |
| OS | overall survival |
| PAMPs | pathogen-associated molecular patterns |
| PD-1 | death protein 1 |
| PGC-1α | peroxisome proliferator-activated receptor γ coactivator-1α |
| PI | phosphatidylinositol |
| PNPLA3 | patatin-like phospholipase domain-containing 3 |
| PPARs | peroxisome proliferator activating receptors |
| PRSs | polygenic risk scores |
| PTEN | phosphatase and tensin homolog |
| PUFAs | polyunsaturated fatty acids |
| ROC | receiver operating characteristics |
| ROS | reactive oxygen species |
| RR | relative risk |
| SAM | S-adenyl methionine |
| SASP | senescence-associated secretory phenotype |
| SERCA | sarco/ER calcium ATPase |
| SIRTs | sirtuins |
| SNP | single nucleotide polymorphism |
| SR-A | scavenger receptor |
| SREBP1 | Sterol Regulatory Element Binding Transcription Factor 1 |
| STZ | streptozotocin |
| STAT3 | Signal Transducer and Activator of Transcription 3 |
| T2D | type 2 diabetes |
| TERT | telomerase reverse transcriptase |
| TG | triglyceride |
| TGF-β | transforming growth factor β |
| TLRs | toll like receptors |
| TM6SF2 | transmembrane 6 superfamily member 2 |
| TMC4 | transmembrane channel like 4 |
| TNF-α | tumor necrosis factor α |
| uPA | urokinase plasminogen activator |
| UPR | unfolded protein response |
| VLDL | very-low density lipoproteins |
| WD | Western diet |
| WNT | wingless |